Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 4 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. US 11883433

    Chimeric antigen receptor comprising anti-mesothelin scFv, and use thereof

    CELLENGENE INC. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted

  2. US 11879016

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted

  3. US 11879017

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted

  4. US 11839659

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein

    Northwestern University · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted

  5. US 11834509

    Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  6. US 11827713

    Chimeric antibody immune effector cell engagers and methods of use thereof

    Nanjing Legend Biotech Co., Ltd · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  7. US 11814432

    Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof

    SANGAMO THERAPEUTICS FRANCE · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  8. US 11807682

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Heath and Human Services · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  9. US 11795215

    Anti-mesothelin chimeric antigen receptor specifically binding to mesothelin

    CELLENGENE INC. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  10. US 11786582

    Human application of engineered chimeric antigen receptor (CAR) T-cells

    The Board of Regents of the University of Texas System · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  11. US 11786553

    Chimeric cytokine receptors bearing a PD-1 ectodomain

    Allogene Therapeutics, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  12. US 11760786

    Chimeric antigen receptors targeting abnormal glycobiology

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  13. US 11753627

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  14. US 11739297

    Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor

    Carisma Therapeutics Inc. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted

  15. US 11732041

    Antibodies against 4G7-derived chimeric antigen receptors

    Allogene Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  16. US 11708423

    Chimeric engulfment receptor molecules and methods of use

    Cero Therapeutics Holdings, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  17. US 11702477

    Bi-functional chimeric proteins and uses thereof

    Orionis Biosciences, Inc · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  18. US 11673953

    DLL3 targeting chimeric antigen receptors and binding agents

    Allogene Therapeutics, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted

  19. US 11661455

    Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety

    Orionis Biosciences, Inc · Granted May 30, 2023 · Expires May 25, 2043

    granted

  20. US 11661459

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Granted May 30, 2023 · Expires May 25, 2043

    granted

  21. US 11655282

    Chimeric engulfment receptor molecules

    Cero Therapeutics Holdings, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted

  22. US 11634459

    Chimeric reporter West Nile/dengue viruses and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  23. US 11591372

    Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  24. US 11590170

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.